A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics

NCT05607199 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

27

Enrollment

INDUSTRY

Sponsor class

Stopped Patient recruitment problems.

Conditions

Solid Tumor, Adult
Acute Myeloid Leukemia
Myelodysplastic Syndromes
Non Hodgkin Lymphoma

Interventions

DRUG: AUR103

Sponsor

Aurigene Discovery Technologies Limited